Celltrion Healthcare, Stock Price -0.3% at This Time... Institutional Investors Net Sell 363,000 Shares in Last 5 Days
As of 7:40 PM on the 19th, Celltrion Healthcare is trading at 99,900 KRW, down 0.3% from the previous day. The trading volume is 1,586,953 shares, which is about 58.86% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
On August 14, Samsung Securities researcher Seo Geun-hee announced a target price of 130,000 KRW for Celltrion Healthcare, stating, "Operating profit exceeded consensus by 30.7%. Despite COVID-19, profitability improved due to stable growth of European biosimilars compared to the previous quarter and strong sales of Truxima in the U.S., reflecting positive variable factors."
Over the past five days, individual investors have net purchased 362,243 shares of Celltrion Healthcare, while foreigners and institutions have net sold 18,260 shares and 363,000 shares, respectively.
※Source: AI Investment Assistant AI Rassiro
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- "Was This Delicious Treat Enjoyed Only by Koreans?"... The K-Dessert Captivating Japan
- Despite Captivating the Nation for Over a Month... "Timmy" the Whale Ultimately Found Dead
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
